Literature DB >> 2118016

A detailed study of the effects of in vitro interferon treatment on the growth of two variants of the B16 mouse melanoma in the lungs: evidence for non-specific effects.

M Blackmore1, S Thompson, G A Turner.   

Abstract

Interferon treatment increases the ability of tumour cells to colonize the lungs. Although it has been suggested that this effect can be explained by increases in the expression of MHC molecules the precise mechanism is still uncertain. The growth in the lungs of a low (F1) and a high colonizing variant (BL6) of the B16 mouse melanoma have been studied after in vitro treatment with interferon. Interferon-gamma, but not interferon-alpha/beta, increased the number of lung colonies formed after intravenous injection, but not after subcutaneous administration. Treatment also increased the sizes of the lung colonies formed and the number of radiolabelled cells retained by the lungs. However, no clear relationship was observed between the number of colonies formed and the concentration of interferon used. The effect of interferon on F1 was greater than on BL6, but the overall number of colonies formed was very similar. These results suggest that interferon increases the adhesiveness of these cell lines in a fairly non-specific manner, that seems unlikely to involve MHC molecules. As a results of this and other studies the importance of interferon in the process of tumour spread seems very questionable.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118016     DOI: 10.1007/bf00058155

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  21 in total

1.  Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells.

Authors:  M Ferrantini; S Pulciani; E Proietti; G Lespinats; A Anastasi; V Ciolli; P Rizza; F Belardelli
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

2.  Target cell expression of MHC antigens is not (always) a turn-off signal to natural killer cells.

Authors:  R Chervenak; R M Wolcott
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

3.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

4.  Interferon-mediated enhancement of metastasis. Are MHC antigens involved?

Authors:  P L Lollini; C De Giovanni; B Del Re; G Nicoletti; G Prodi; P Nanni
Journal:  Clin Exp Metastasis       Date:  1987 Oct-Dec       Impact factor: 5.150

5.  Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell.

Authors:  K Taniguchi; K Kärre; G Klein
Journal:  Int J Cancer       Date:  1985-10-15       Impact factor: 7.396

6.  Analysis of aprotinin-induced enhancement of metastasis of Lewis lung tumors in mice.

Authors:  G A Turner; L Weiss
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

Review 7.  Effects of interferon on differentiation of normal and tumor cells.

Authors:  P B Fisher; S Grant
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

8.  Immuno-selection in vivo of H-2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence.

Authors:  S Katzav; S Segal; M Feldman
Journal:  Int J Cancer       Date:  1984-03-15       Impact factor: 7.396

9.  Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread.

Authors:  M Zöller; A Strubel; G Hämmerling; G Andrighetto; A Raz; A Ben-Ze'ev
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

10.  Recombinant human IFN-gamma, but not IFN-alpha or IFN-beta, enhances MHC- and non-MHC-encoded glycoproteins by a protein synthesis-dependent mechanism.

Authors:  P Giacomini; R Tecce; R Gambari; A Sacchi; P B Fisher; P G Natali
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.